• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

二十年的临床基因治疗——成功终于日益显现。

Two decades of clinical gene therapy--success is finally mounting.

作者信息

Herzog Roland W, Cao Ou, Srivastava Arun

机构信息

Department of Pediatrics, University of Florida College of Medicine, 2033 Mowry Road, Gainesville, Florida 32610, USA.

出版信息

Discov Med. 2010 Feb;9(45):105-11.

PMID:20193635
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3586794/
Abstract

Human gene therapy has made substantial progress since the initiation of the first clinical trials 20 years ago. Here, we summarized important applications of gene transfer protocols in the treatment of various human diseases using different viral vectors. Recent successful trials on the treatment of ocular diseases and inherited immune deficiencies are particularly encouraging and have raised hopes that human gene therapy as a standard treatment option will finally become a reality. While immune responses and insertional mutagenesis pose obstacles for this novel form of molecular medicine, continuous progress suggests that a wider range of diseases can be treated with gene therapy in the future.

摘要

自20年前首次开展临床试验以来,人类基因治疗已取得了重大进展。在此,我们总结了使用不同病毒载体的基因转移方案在治疗各种人类疾病中的重要应用。近期在眼科疾病和遗传性免疫缺陷治疗方面的成功试验尤其令人鼓舞,并燃起了人们的希望,即人类基因治疗作为一种标准治疗选择最终将成为现实。虽然免疫反应和插入诱变给这种新型分子医学带来了障碍,但持续的进展表明,未来基因治疗可以治疗更广泛的疾病。

相似文献

1
Two decades of clinical gene therapy--success is finally mounting.二十年的临床基因治疗——成功终于日益显现。
Discov Med. 2010 Feb;9(45):105-11.
2
State-of-the-art gene-based therapies: the road ahead.基于基因的最先进疗法:前路漫漫。
Nat Rev Genet. 2011 May;12(5):316-28. doi: 10.1038/nrg2971. Epub 2011 Apr 6.
3
[Developments in gene delivery vectors for ocular gene therapy].[用于眼部基因治疗的基因递送载体的进展]
Med Sci (Paris). 2015 May;31(5):529-37. doi: 10.1051/medsci/20153105015. Epub 2015 Jun 9.
4
Gene therapy for primary immunodeficiencies: Part 2.原发性免疫缺陷的基因治疗:第 2 部分。
Curr Opin Immunol. 2012 Oct;24(5):585-91. doi: 10.1016/j.coi.2012.07.012. Epub 2012 Aug 18.
5
[Ten years of gene therapy: thoughts and perspectives].[基因治疗十年:思考与展望]
Med Sci (Paris). 2010 Feb;26(2):115-8. doi: 10.1051/medsci/2010262115.
6
Viral Vectors for Gene Therapy: Translational and Clinical Outlook.病毒载体基因治疗:转化与临床展望。
Annu Rev Biomed Eng. 2015;17:63-89. doi: 10.1146/annurev-bioeng-071813-104938.
7
A call for physiopathological ethics.对生理病理学伦理学的呼吁。
Mol Ther. 2008 Nov;16(11):1771-2. doi: 10.1038/mt.2008.218.
8
Ocular gene therapy: current progress and future prospects.眼部基因治疗:当前进展与未来前景。
Trends Mol Med. 2009 Jan;15(1):23-31. doi: 10.1016/j.molmed.2008.11.003. Epub 2008 Dec 25.
9
Recent advances in ocular gene therapy.眼部基因治疗的最新进展
Curr Opin Ophthalmol. 2009 Sep;20(5):377-81. doi: 10.1097/ICU.0b013e32832f802a.
10
A look to future directions in gene therapy research for monogenic diseases.单基因疾病基因治疗研究的未来方向展望。
PLoS Genet. 2006 Sep 29;2(9):e133. doi: 10.1371/journal.pgen.0020133.

引用本文的文献

1
Building Better Medicine: Translational Justice and the Quest for Equity in US Healthcare.打造更优质的医学:转化正义与美国医疗保健中的公平追求
Am J Bioeth. 2025 Jun;25(6):11-25. doi: 10.1080/15265161.2025.2457713. Epub 2025 Feb 23.
2
Gene Therapy with Chitosan Nanoparticles: Modern Formulation Strategies for Enhancing Cancer Cell Transfection.壳聚糖纳米颗粒基因治疗:增强癌细胞转染的现代制剂策略
Pharmaceutics. 2024 Jun 27;16(7):868. doi: 10.3390/pharmaceutics16070868.
3
Gelatin methacryloyl granular scaffolds for localized mRNA delivery.用于局部mRNA递送的甲基丙烯酰化明胶颗粒支架
Aggregate (Hoboken). 2024 Apr;5(2). doi: 10.1002/agt2.464. Epub 2023 Nov 20.
4
Inner leaflet cationic lipid increases nucleic acid loading independently of outer leaflet lipid charge in asymmetric liposomes.不对称脂质体中外叶带电荷的阳离子脂质对内叶带的核酸负载增加独立于外叶带脂质的电荷。
Methods. 2023 Nov;219:16-21. doi: 10.1016/j.ymeth.2023.08.015. Epub 2023 Sep 7.
5
Novel therapies for proliferative retinopathies.增殖性视网膜病变的新型疗法。
Ther Adv Chronic Dis. 2022 Dec 2;13:20406223221140395. doi: 10.1177/20406223221140395. eCollection 2022.
6
Recent advances in gene therapy: genetic bullets to the root of the problem.基因治疗的最新进展:直击问题根源的基因子弹。
Clin Exp Med. 2023 Aug;23(4):1107-1121. doi: 10.1007/s10238-022-00925-x. Epub 2022 Oct 25.
7
EV Cargo Sorting in Therapeutic Development for Cardiovascular Disease.心血管疾病治疗开发中的 EV 货物分拣。
Cells. 2021 Jun 15;10(6):1500. doi: 10.3390/cells10061500.
8
Gene therapy in PIDs, hemoglobin, ocular, neurodegenerative, and hemophilia B disorders.原发性免疫缺陷病、血红蛋白病、眼部疾病、神经退行性疾病和乙型血友病中的基因治疗。
Open Life Sci. 2021 May 3;16(1):431-441. doi: 10.1515/biol-2021-0033. eCollection 2021.
9
Development and Use of Gene Therapy Orphan Drugs-Ethical Needs for a Broader Cooperation Between the Pharmaceutical Industry and Society.基因治疗孤儿药的研发与应用——制药行业与社会更广泛合作的伦理需求
Front Med (Lausanne). 2020 Dec 23;7:608249. doi: 10.3389/fmed.2020.608249. eCollection 2020.
10
Recent Advancements in Gene Therapy for Hereditary Retinal Dystrophies.遗传性视网膜营养不良基因治疗的最新进展
Turk J Ophthalmol. 2017 Dec;47(6):338-343. doi: 10.4274/tjo.41017. Epub 2017 Dec 25.

本文引用的文献

1
Follistatin gene delivery enhances muscle growth and strength in nonhuman primates.卵泡抑素基因递送增强了非人灵长类动物的肌肉生长和力量。
Sci Transl Med. 2009 Nov 11;1(6):6ra15. doi: 10.1126/scitranslmed.3000112.
2
Dopamine gene therapy for Parkinson's disease in a nonhuman primate without associated dyskinesia.在非人类灵长类动物中进行的帕金森病多巴胺基因治疗,无相关运动障碍。
Sci Transl Med. 2009 Oct 14;1(2):2ra4. doi: 10.1126/scitranslmed.3000130.
3
Genomic instability and myelodysplasia with monosomy 7 consequent to EVI1 activation after gene therapy for chronic granulomatous disease.基因治疗慢性肉芽肿病后 EVI1 激活导致基因组不稳定和 7 号单体性骨髓增生异常。
Nat Med. 2010 Feb;16(2):198-204. doi: 10.1038/nm.2088. Epub 2010 Jan 24.
4
Reengineering a receptor footprint of adeno-associated virus enables selective and systemic gene transfer to muscle.对腺相关病毒的受体足迹进行重新设计可实现向肌肉的选择性全身基因转移。
Nat Biotechnol. 2010 Jan;28(1):79-82. doi: 10.1038/nbt.1599. Epub 2009 Dec 27.
5
Gene therapy. Beta-thalassemia treatment succeeds, with a caveat.基因疗法。β地中海贫血治疗取得成功,但有一项限制条件。
Science. 2009 Dec 11;326(5959):1468-9. doi: 10.1126/science.326.5959.1468-b.
6
Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy.采用慢病毒载体的造血干细胞基因疗法治疗X连锁肾上腺脑白质营养不良症
Science. 2009 Nov 6;326(5954):818-23. doi: 10.1126/science.1171242.
7
Age-dependent effects of RPE65 gene therapy for Leber's congenital amaurosis: a phase 1 dose-escalation trial.RPE65基因疗法治疗莱伯先天性黑蒙的年龄依赖性效应:一项1期剂量递增试验。
Lancet. 2009 Nov 7;374(9701):1597-605. doi: 10.1016/S0140-6736(09)61836-5. Epub 2009 Oct 23.
8
Evading the immune response upon in vivo gene therapy with viral vectors.体内使用病毒载体进行基因治疗时对免疫反应的规避。
Curr Opin Mol Ther. 2009 Oct;11(5):493-503.
9
Gene therapy for red-green colour blindness in adult primates.成年灵长类动物红绿色盲的基因治疗。
Nature. 2009 Oct 8;461(7265):784-7. doi: 10.1038/nature08401. Epub 2009 Sep 16.
10
Vision 1 year after gene therapy for Leber's congenital amaurosis.莱伯先天性黑矇症基因治疗1年后的视力情况。
N Engl J Med. 2009 Aug 13;361(7):725-7. doi: 10.1056/NEJMc0903652.